A very encouraging year-end update: trading ahead of expectations, with a robust performance from AES built on record order book levels and strong performances in many of its businesses. The delay in some medical development expenditure boosts FY24 but does not reduce FY25, illustrating management confidence in underlying performance. With a £4m increase in adj EBITDA guidance in FY24, the boost to EPS is substantial. We maintain our 495p target price, although we recognise that if it is success ....
![working](/images/WorkingLarge.gif)
19 Jun 2024
Avingtrans - Trading ahead of expectations
![](/images/orange-lock.png)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Avingtrans - Trading ahead of expectations
Avingtrans plc (AVG:LON) | 368 0 0.0% | Mkt Cap: 121.6m
- Published:
19 Jun 2024 -
Author:
David Buxton -
Pages:
6 -
A very encouraging year-end update: trading ahead of expectations, with a robust performance from AES built on record order book levels and strong performances in many of its businesses. The delay in some medical development expenditure boosts FY24 but does not reduce FY25, illustrating management confidence in underlying performance. With a £4m increase in adj EBITDA guidance in FY24, the boost to EPS is substantial. We maintain our 495p target price, although we recognise that if it is success ....